Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by gebremeskelon Jun 28, 2019 11:16pm

144 Views

Post# 29875561

RE:New Year's 2020 will be good, but 2022 will be special!

Seriously newdaydawning, do you think the most effective treatment for cancer ever devised, once it has proved its efficacy is going to be valued at 2$ a share? While the company that produces the Cologuard test for colon cancer is $117 US a share?

newdaydawning wrote: I believe it's a safe bet TLT will touch new highs in a blue-sky break-out before year-end. There will be much reason to cheer as TLT repeats and reinforces its stature as a TSX-V Top 50 performer in 2019.

But the big celebration will take place as we usher in 2022. TLT will be trading north of $2.00, at minimum.

Bullboard Posts

The top 10 artificial intelligence penny stocks